gameChange for Anxiety

The University of Texas Health Science Center at Houston, Houston, TX
AnxietygameChange - Device
Eligibility
18 - 30
All Sexes

Study Summary

This trial will test if a VR intervention can help reduce anxiety symptoms in college students, by having them undergo six VR sessions over the course of three weeks.

Eligible Conditions
  • Anxiety

Treatment Effectiveness

Study Objectives

11 Primary · 4 Secondary · Reporting Duration: Week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)

Week 1
Change in depressive symptoms as assessed by score on the Patient Health Questionnaire-4 (PHQ-4)
Week 3
Change in Psychomotor agitation such as Fidgeting
Change in Psychomotor agitation such as Rubbing hands/neck/head
Change in Psychomotor agitation such as pacing
Change in anxiety related behaviors such as Laughter
Change in anxiety related behaviors such as Negative self-talk
Change in anxiety related behaviors such as Utterances about experience
Change in anxiety related behaviors such as rate of speech
Change in anxiety related behaviors such as volume of speech
Change in physiology such as perspiration
Week 3
Change in acceptability as assessed by the rating on a short questionnaire
change in feasibility as assessed by the rating on a short questionnaire
Week 3
Change in perceived presence in the virtual environment (as indicated by continuous score on the Igroup Presence Questionnaire (IPQ)
Week 3
Change in self-reported academic performance as assessed by the Motivated Strategies for Learning Questionnaire (MSLQ)
Change in state anxiety as assessed by the Liebowitz Social Anxiety Scale-Self Report version (LSAS-SR)

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

1 Treatment Group

gameChange
1 of 1

Experimental Treatment

100 Total Participants · 1 Treatment Group

Primary Treatment: gameChange · No Placebo Group · N/A

gameChange
Device
Experimental Group · 1 Intervention: gameChange · Intervention Types: Device

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: week 1(session1 and session 2), week 2( session 3 and session 4), week 3 (session 5 and session 6)

Who is running the clinical trial?

The University of Texas Health Science Center, HoustonLead Sponsor
836 Previous Clinical Trials
263,941 Total Patients Enrolled
1 Trials studying Anxiety
20 Patients Enrolled for Anxiety
Tsai Jack, PhDPrincipal InvestigatorThe University of Texas Health Science Center, Houston

Eligibility Criteria

Age 18 - 30 · All Participants · 0 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
Texas75.0%
Minnesota25.0%
How old are they?
18 - 65100.0%
What site did they apply to?
The University of Texas Health Science Center at Houston100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%

How responsive is this trial?

Average response time
  • < 2 Days
Most responsive sites:
  1. The University of Texas Health Science Center at Houston: < 48 hours
Typically responds via
Email100.0%

Frequently Asked Questions

Could I potentially qualify to participate in this research endeavor?

"This research effort is searching for 100 participants, between 18 and 30 years of age, who have been diagnosed with anxiety. To qualify to join this study, individuals must also be fluent in English and score a minimum of three on the GAD-2 scale as well as be enrolled at The University of Texas Health Science Center School of Public Health San Antonio regional campus." - Anonymous Online Contributor

Unverified Answer

Is there an opportunity for individuals to partake in this research project?

"According to the official record on clinicaltrials.gov, this trial is actively seeking participants with an initial posting date of April 1st 2022 and a recent edit made on April 12th 2022." - Anonymous Online Contributor

Unverified Answer

What are the main goals of this experiment?

"The primary efficacy endpoint of this clinical trial, monitored over three weeks (during six sessions), will be the alteration in state anxiety as evaluated through the Liebowitz Social Anxiety Scale-Self Report. Secondary objectives include a change in self-reported academic performance based on responses to the Motivated Strategies for Learning Questionnaire (MSLQ) with a maximum score of 63; an adjustment in perceived presence within virtual environments via continuous scoring from Igroup Presence Questionnaire (IPQ); and alterations to acceptability gauged by ratings given on a short user questionnaire developed by gameChange which is scored from one to five, with higher numbers indicating stronger agreement" - Anonymous Online Contributor

Unverified Answer

Is the age range for participation in this research inclusive of individuals aged 50 and above?

"This clinical study enforces an age restriction, where the minimum permissible age is 18 and the maximum allowable age is 30." - Anonymous Online Contributor

Unverified Answer

What is the optimal number of participants for this clinical experiment?

"Affirmative. Clinicaltrials.gov documents confirm that this medical trial, first published on April 1st 2022, is actively recruiting volunteers. Approximately 100 participants need to be enrolled from the single site participating in this study." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.